Literature DB >> 6932456

Vasoactive intestinal polypeptide as a biochemical marker for polymorphonuclear leukocytes.

M S O'Dorisio, T M O'Dorisio, S Cataland, S P Balcerzak.   

Abstract

VIP is a 28 amino acid peptide found in highest concentration in central and peripheral nervous tissue. This study measured VIP in pure populations of peripheral blood cells to determine the presence or absence of VIP in noninnervated tissues. Cell populations were purified by Ficoll-hypaque gradient centrifugation followed by dextran sedimentation or differential adherence to culture plates. Platelets were purified by differential centrifugation. VIP was isolated by acid-ethanol extraction and quantified by radioimmunoassay. A mean value of 1.1 +/- 0.6 ng of VIP per 10(8) cells was extracted from PMNs. This peptide appears to be a specific marker for PMNs, since it was not measurable in pure populations of lymphocytes, monocytes, erythrocytes, or platelets. Mononuclear cells obtained from five patients with AML and seven patients with CML contained measurable VIP, whereas mononuclear cells from nine of 10 patients with AMML and from five patients with ALL contained very low or unmeasurable levels of VIP. Thus, although the role of VIP in normal PMN function is unknown, measurement of VIP in leukemic cells may aid in the differential diagnosis of acute leukemias.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6932456

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  14 in total

1.  Vasoactive intestinal peptide stimulates immunoglobulin production and growth of human B cells.

Authors:  C Ishioka; A Yoshida; H Kimata; H Mikawa
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

Review 2.  Inflammatory and immune pathways in the pathogenesis of periodontal disease.

Authors:  Ali Cekici; Alpdogan Kantarci; Hatice Hasturk; Thomas E Van Dyke
Journal:  Periodontol 2000       Date:  2014-02       Impact factor: 7.589

Review 3.  Vasoactive intestinal peptide.

Authors:  S I Said
Journal:  J Endocrinol Invest       Date:  1986-04       Impact factor: 4.256

4.  Vasoactive intestinal peptide signaling axis in human leukemia.

Authors:  Glenn Paul Dorsam; Keith Benton; Jarrett Failing; Sandeep Batra
Journal:  World J Biol Chem       Date:  2011-06-26

5.  Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin.

Authors:  T J Williams
Journal:  Br J Pharmacol       Date:  1982-11       Impact factor: 8.739

Review 6.  Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease.

Authors:  S G R Smalley; P A Barrow; N Foster
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

7.  Lack of circadian rhythm of plasma concentrations of vasoactive intestinal peptide in patients with orthotopic heart transplants.

Authors:  P Cugini; P Lucia; G Scibilia; L Di Palma; A R Cioli; A Cianetti; L Gasbarrone; R Canova; B Marino
Journal:  Br Heart J       Date:  1993-10

Review 8.  Neuroendocrine modulation of the immune system. Possible implications for inflammatory bowel disease.

Authors:  F Shanahan; P Anton
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

9.  Studies on the trigeminal antidromic vasodilatation and plasma extravasation in the rat.

Authors:  R Couture; A C Cuello
Journal:  J Physiol       Date:  1984-01       Impact factor: 5.182

10.  Changes of colonic vasoactive intestinal peptide and cholinergic activity in rats with chemical colitis.

Authors:  S Kishimoto; H Kobayashi; S Shimizu; K Haruma; T Tamaru; G Kajiyama; A Miyoshi
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.